2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1356517817 MD
Verify on CMS →

NOLAWIT TESFAYE, MD

Endocrinology, Diabetes & Metabolism Physician in MINNEAPOLIS, Minnesota. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
820
Medicare Part D claims · 169 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.3405/100
▼ 1 pts below national avg 83.1 · [object Object]

What the federal data shows

NOLAWIT TESFAYE, MD reported a CMS MIPS final score of 82.3405/100 — below the 83.1 national average — and filed 820 Medicare Part D claims in 2023.

82.3405/100
MIPS score · -1 vs avg
820
Part D claims, 2023
59%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NOLAWIT TESFAYE, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

82 39th percentile higher than 39% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NOLAWIT TESFAYE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 3 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NOLAWIT TESFAYE, MD?

Near national average

NPI registry status

Active

Issued 05/05/2008

NPI 1356517817

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

820 69% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

82.3405/100 0.7594999999999885% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Minnesota

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Minnesota providers

Minnesota providers

Endocrinology, Diabetes & Metabolism Physician share within Minnesota

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Minnesota

Medicare quality performance — MIPS

NOLAWIT TESFAYE, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Near national average
MIPS Final Score
82.3405/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 82.3405/100 vs national avg 83.1

0%100%National avg83%82.3%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 82.3405/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NOLAWIT TESFAYE, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 2450 RIVERSIDE AVE, MINNEAPOLIS, MN, 55454, with a listed phone of (612) 672-6000. NPI 1356517817 was issued on 05/05/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TESFAYE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 820 prescription claims written by this provider, covering 169 Medicare beneficiaries and totaling roughly $370K in drug spend, split 41% brand-name and 59% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.3405/100 for the 2023 performance year (Quality 81.5407, Cost 38.1722), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2450 RIVERSIDE AVE
MINNEAPOLIS, MN 55454

Provider Details

NPI 1356517817
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 05/05/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.3405
Final Score
Avg: 83.1
81.5407
Quality
38.1722
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where NOLAWIT TESFAYE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FAIRVIEW EXPRESS CARE
MINNEAPOLIS, MN
HEALTHEAST MEDICAL RESEARCH INSTITUTE
MAPLEWOOD, MN
UNIVERSITY OF MINNESOTA HEALTH CLINICS AND SURGERY CENTER INC
MINNEAPOLIS, MN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

NOLAWIT TESFAYE, MD — brand share 41.0%
Specialty average (est.)

41% brand-name claims vs 59% generic, on 820 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

820
Total Claims
$370K
Total Drug Cost
169
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,607
Total Day Supply
47,388
Brand vs Generic
41% brand / 59% generic
Brand Drug Cost
$337K
Generic Drug Cost
$12K

Patient Demographics

Average Patient Age
70.9 years
Avg HCC Risk Score
1.70
Gender Split
74% female / 26% male
Age Distribution
<65: 31, 65-74: 64, 75-84: 62, 85+: 12

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NOLAWIT TESFAYE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
122
Alendronate Sodium
66
Methimazole
62
Risedronate Sodium
43
Hydrochlorothiazide
38
Ozempic
Semaglutide
38
Jardiance
Empagliflozin
28
Metformin Hcl Er
Metformin Hcl
26
Synthroid
Levothyroxine Sodium
23
Hydrocortisone
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How NOLAWIT TESFAYE, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

NOLAWIT TESFAYE, MD's 820 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Minnesota

Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as TESFAYE.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NOLAWIT TESFAYE, MD's specialty?
NOLAWIT TESFAYE, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in MINNEAPOLIS, Minnesota. Credentials: MD.
How much does NOLAWIT TESFAYE, MD prescribe under Medicare Part D?
In 2023, NOLAWIT TESFAYE, MD wrote 820 Medicare Part D claims totaling $370K in drug costs for 169 beneficiaries.
What is NOLAWIT TESFAYE, MD's Medicare quality score?
NOLAWIT TESFAYE, MD has a CMS MIPS Final Score of 82.3405/100 (Quality: 81.5407, Cost: 38.1722). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NOLAWIT TESFAYE, MD located?
NOLAWIT TESFAYE, MD is located at 2450 RIVERSIDE AVE, MINNEAPOLIS, MN, 55454. Phone: (612) 672-6000.
What is NOLAWIT TESFAYE, MD's NPI number?
NOLAWIT TESFAYE, MD's National Provider Identifier (NPI) is 1356517817, issued on 05/05/2008.
Does NOLAWIT TESFAYE, MD prescribe more brand-name or generic drugs?
NOLAWIT TESFAYE, MD's prescribing is 41% brand-name and 59% generic drugs by claim count, with $337K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does NOLAWIT TESFAYE, MD prescribe most often?
Based on 2023 Medicare Part D data, NOLAWIT TESFAYE, MD's most frequently prescribed drugs include Levothyroxine Sodium, Alendronate Sodium, Methimazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NOLAWIT TESFAYE, MD accept Medicare?
NOLAWIT TESFAYE, MD appears in CMS Medicare data with 820 Part D claims and 169 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NOLAWIT TESFAYE, MD's credentials?
NOLAWIT TESFAYE, MD's NPI is 1356517817 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology